May 17, 2020

How to look good in every photo

Wake Forest University
perfect profile picture
slimmer fac
Admin
4 min
How to look good in every photo
Look to your right A US study conducted by Wake Forest University has revealed that the left side of the face is more attractive than the right, appar...

realbuzz.com - healthy active living

Look to your right

A US study conducted by Wake Forest University has revealed that the left side of the face is more attractive than the right, apparently due to the fact that this side of the face shows more emotion. To capture the perfect profile picture, look slightly to the right to reveal your ‘best’ side. This can also help to give the illusion of a slimmer face for those with rounder faces.

Choose your makeup carefully

For the perfect photo-ready appearance, make sure you avoid light reflective or mineral foundations containing high amounts of titanium dioxide (a reflective pigment). Although these foundations are great for an everyday luminous look, the flash of a camera can quickly transform your dewy complexion to a ghostly white one as the white light reflects back from the camera. Once you have applied a suitable foundation, finish your look with some face powder to help eliminate shine.

Accentuate your best features 

To look your sparkling best in photos, make sure you emphasise your favourite features to make them the standout feature in your snapshot. Try playing up your eyes with some eyeliner or false lashes. Alternatively, perk up your pout with some bright lipstick. Also, make the most of your best body features with an outfit that complements your shape and colouring.

Look away from the lens

Nobody wants glaring red or half-shut eyes ruining an otherwise great photo, so make sure you avoid this by focusing your eyes just slightly above or below the lens. Looking directly at the lens causes light to flash off the retina, leading to the red eye effect. Looking slightly away from the camera will also reduce the risk of those mid-blink shots.

 Avoid "red eye" shots
 
As “red eye” in photographs is caused by light reflecting off the back of the eye, those with large pupils are more likely to suffer from this pesky problem. If averting your gaze from the camera is not doing the trick, another tip for alleviating the red eye effect is to make sure photos are taken in well lit environment or to look at a bright light just prior to the photograph being taken to make your pupils smaller.
 
Banish the double chin
 
There’s nothing worse than spotting a picture of yourself sporting a double chin where you previously only had one, yet sadly this happens to the best of us. To avoid the appearance of a double chin in photographs, make sure that the camera is just above or at your eye level. Also, try tilting your head up and jutting your jaw out slightly – you may want to practise this one first in the mirror to stay looking natural!

Avoid direct light
 
It may not always be possible to control the lighting for your photographs and, unless you happen to be a professional model, you most likely won’t have someone on hand to make sure it’s just right. However, it is worth bearing in mind that direct light from above can cast shadows on your face and accentuate the appearance of under-eye shadows. Opt for areas with softer lighting or head to the shade if outdoors.
 
Pose like a pro

If you’re posing for a full body shot, try the classic celeb pose of turning your body three quarters of the way towards the camera, with one shoulder closer to the camera and one foot in front of the other. This will make you body appear slimmer than if you were facing the camera face on. Try keeping your back straight with your shoulders back and your stomach in (just try not to suck it in too much, you won’t be fooling anyone!).

Master the perfect smile

Many of us focus on our mouths when smiling; however, in the words of supermodel Tyra Banks, it’s all about the “smeyes” (smiling with your eyes). Rather than forcing a grin, think about something that makes you happy for a more natural smile. You may also want to perfect your personal smile to work with your features. For instance, a beaming smile works great for those with good teeth, while a more relaxed half smile will make small eyes appear larger and lips appear fuller.

Practise your pose

If you’re really keen to capture the perfect photo, the best thing you can do is practise beforehand. Experiment with different face and body angles, smiles and facial expressions to find what works for you, either in front of the mirror or with your own camera. Once you have discovered which looks you like best, you are ready to unleash them at every photo opportunity, making sure you look perfect each time.

http://www.realbuzz.com/articles/10-ways-to-be-more-beautiful

http://www.realbuzz.com/articles/7-quick-tricks-for-a-beautiful-body

Share article

Apr 30, 2021

The challenges to vaccine distribution affecting everyone

covid-19vaccine
vaccinesupply
Supplychain
Blockchain
Jonathan Colehower
5 min
The challenges to vaccine distribution affecting everyone
Jonathan Colehower, CEO at CargoChain, describes the COVID-19 vaccine distribution challenges impacting every country, organisation and individual...

While it is comforting to know that vaccines against COVID-19 are showing remarkable efficacy, the world still faces intractable challenges with vaccine distribution. Specifically, the sheer number of vaccines required and the complexity of global supply chains are sure to present problems we have neither experienced nor even imagined. 

Current projections estimate that we could need 12-15 billion doses of vaccine, but the largest vaccine manufacturers produce less than half this volume in a year. To understand the scale of the problem, imagine stacking one billion pennies – you would have a stack that is 950 miles high. Now, think of that times ten. This is a massive problem that one nation can’t solve alone.  

Production capacity 

Even if we have a vaccine – can we make enough? Based on current projections, Pfizer expects to produce up to 1.3 billion doses this year. Moderna is working to expand its capacity to one billion units this year. Serum Institute of India, the world’s largest vaccine producer, is likely to produce 60% of the 3 billion doses committed by AstraZeneca, Johnson & Johnson and Sanofi. This leaves us about 7 billion doses short. 

Expanding vaccine production for most regions in the world is complicated and time-consuming. Unlike many traditional manufacturing operations that can expand relatively quickly and with limited regulation, pharmaceutical production must meet current good manufacturing practice (CGMP) guidelines. So, not only does it take time to transition from R&D to commercial manufacturing, but it could also take an additional six months to achieve CGMP certification. 

The problem becomes even more complex when considering the co-products required. Glass vials and syringes are just two of the most essential co-products needed to produce a vaccine. Last year, before COVID-19, global demand for glass vials was 12 billion. Even if it is safe to dispense ten doses per vial, there is certain to be significant pressure on world supply of the materials needed to package and distribute a vaccine.

It is imperative drug manufacturers and their raw material suppliers have clear visibility of production plans and raw material availability if there is any hope of optimizing scarce resources and maximising production yield.

Distribution requirements

It is widely known by now that temperature is a critical factor for the COVID-19 vaccine. Even the regions with the most developed logistics infrastructures and resources needed to support a cold-chain network are sure to struggle with distribution.

For the United States alone, State and local health agencies have determined distribution costs will exceed $8.4 billion, including $3 billion for workforce recruitment and training; $1.2 billion for cold-chain, $1 billion vaccination sites and $0.5 billion IT upgrades.  

The complexity of the problem increases further when considering countries such as India that do not have cold-chain logistics networks that meet vaccine requirements. Despite India’s network of 28,000 cold-chain units, none are capable of transporting vaccines below -25°Celsius. While India’s Serum Institute has licensed to manufacture AstraZeneca’s vaccine, which can reportedly be stored in standard refrigerated environments, even a regular vaccine cold chain poses major challenges.

Furthermore, security will undoubtedly become a significant concern that global authorities must address with a coordinated solution. According to the Pharmaceutical Security Institute, theft and counterfeiting of pharmaceutical products rose nearly 70% over the past five years. As with any valuable and scarce product, counterfeits will emerge. Suppliers and producers are actively working on innovative approaches to limit black-market interference. Corning, for example, is equipping vials with black-light verification to curb counterfeiting.

Clearly, this is a global problem that will require an unprecedented level of collaboration and coordination.

Disconnected information systems 

While it is unreasonable to expect every country around the world will suddenly adopt a standard technology that would provide immediate, accurate and available information for everyone, it is not unreasonable to think that we can align on a standard taxonomy that can serve as a Rosetta Stone for collaboration. 

A shared view of the situation (inventory, raw materials, delivery, defects) will provide every nation with the necessary information to make life-saving decisions, such as resource pooling, stock allocations and population coverage.

By allowing one central authority, such as the World Health Organization, to organize and align global leaders to a single collaboration standard, such as GS1, and a standard sharing protocol, such as DSCSA, then every supply chain participant will have the ability to predict, plan and execute in a way that maximises global health.

Political influence and social equality 

As if we don’t have enough stress and churn in today’s geopolitical environment, we must now include the challenge of “vaccine nationalism.” While this might not appear to be a supply chain problem, per se, it is a critical challenge that will hinge on supply chain capabilities.

In response to the critical supply issues the world experienced with SARS-CoV-2, the World Health Organization, Gavi, the Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI) formed Covax: a coalition dedicated to equitable distribution of 2 billion doses of approved vaccines to its 172 member countries. Covax is currently facilitating a purchasing pool and has made commitments to buy massive quantities of approved vaccines when they become available.  

However, several political powerhouse countries, such as the United States and Russia, are not participating. Instead, they are striking bilateral deals with drug manufacturers – essentially, competing with the rest of the world to secure a national supply. Allocating scarce resources is never easy, but when availability could mean the difference between life and death, it becomes almost impossible.

Global production, distribution and social equality present dependent yet conflicting realities that will demand global supply chains provide complete transparency and an immutable chain of custody imperative to vaccine distribution. 

The technology is available today – we just need to use it. We have the ability to track every batch, pallet, box, vile and dose along the supply chain. We have the ability to know with absolute certainty that the vaccine is approved, where and when it was manufactured, how it was handled and whether it was compromised at any point in the supply chain. Modern blockchain technologies should be applied so that every nation, institution, regulator, doctor and patient can have confidence in knowing that they are making an impact in eradicating COVID-19.

Share article